Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from ELEVAI Labs Inc. ( (ELAB) ) is now available.
On June 24, 2025, PMGC Holdings Inc. announced a non-binding Letter of Intent to acquire a U.S.-based CNC machining company specializing in aerospace and defense components, generating $4.5 million in annual revenue. This acquisition aligns with PMGC’s strategy to enhance its portfolio with specialized U.S. manufacturers, particularly in the aerospace sector, which is experiencing increased demand for certified domestic suppliers due to federal incentives and geopolitical shifts.
Spark’s Take on ELAB Stock
According to Spark, TipRanks’ AI Analyst, ELAB is a Underperform.
ELEVAI Labs Inc. is rated poorly due to major financial weaknesses, including negative revenue and cash flow issues, which are exacerbated by adverse technical indicators. The lack of favorable valuation metrics further weighs down the stock’s score. The absence of applicable corporate events means no positive catalysts are present to offset these challenges.
To see Spark’s full report on ELAB stock, click here.
More about ELEVAI Labs Inc.
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The company’s portfolio includes subsidiaries like Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC, with a focus on maximizing growth and value across multiple sectors.
Average Trading Volume: 982,192
Technical Sentiment Signal: Sell
Current Market Cap: $2.83M
For a thorough assessment of ELAB stock, go to TipRanks’ Stock Analysis page.